Arvinas ARVN
NASDAQ ARVN
$9.44 +0.13 (+1.34%)
As of: Sep 4, 2026 · 1:38 PM EDT

Arvinas (ARVN) Change in Accured Expenses (2017 - 2026)

Arvinas (ARVN) posted quarterly Change in Accured Expenses of -$6.8 million for Q1 2026, down 750.0% year-over-year from $1.0 million in Q1 2025, and down 142.5% quarter-over-quarter from $16.0 million in Q4 2025.

Analysis

Arvinas (ARVN) Change in Accured Expenses (2017 - 2026) Analysis & Trends

Arvinas' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$6.8 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 750.0% year-over-year to -$6.8 million; the TTM figure through Mar 2026 stood at -$7.7 million (down 22.22% YoY), while the FY2025 annual figure was -$1.7 million, up 91.98% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$6.8 million, down from $16.0 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $25.2 million in Q4 2022, with the low at -$16.8 million in Q2 2025.
  • The 5-year median for Change in Accured Expenses is -$100000.0 (2025), against an average of $458823.5.
  • The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses jumped 3750.0% in 2022, then sank 1033.33% in 2025.
  • Arvinas' Change in Accured Expenses stood at $25.2 million in 2022, then plunged by 94.84% to $1.3 million in 2023, then tumbled by 476.92% to -$4.9 million in 2024, then surged by 426.53% to $16.0 million in 2025, then tumbled by 142.5% to -$6.8 million in 2026.
  • Business Quant data shows ARVN's Change in Accured Expenses at -$6.8 million in Q1 2026, $16.0 million in Q4 2025, and -$100000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 55.78 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 68.82 Mn
10 Arvinas 609.44 Mn 41.54 Mn - -10.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.10 Mn
Mar 31, 2026 -6.80 Mn
Dec 31, 2025 16.00 Mn
Sep 30, 2025 -100,000.00
Jun 30, 2025 -16.80 Mn
Mar 31, 2025 -800,000.00
Dec 31, 2024 -4.90 Mn
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 -15.70 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 16.60 Mn
Jun 30, 2023 8.20 Mn
Mar 31, 2023 -8.80 Mn
Dec 31, 2022 25.20 Mn
Sep 30, 2022 7.70 Mn
Jun 30, 2022 2.90 Mn
Mar 31, 2022 -15.60 Mn
Dec 31, 2021 35.50 Mn
Sep 30, 2021 200,000.00